Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
Most Cited Paper
in Virus-based gene therapy research
18 Months Post-Publication
Class of 2026
“Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026/
Topics
Oncolytic virus · rVSV-LCMVG · Adoptive cell therapy · mRNA vaccine · Combination therapy · tumor microenvironment · B16 tumor-bearing mice · CD8+ T cells · Neutralizing Antibodies · cytokine and chemokine levels · PD-1 down-regulation · Effector T-Cell Response · Intratumoral injection · Intravenous Administration · Tumor antigens · T-cell recruitment · immunosuppressive to immunosensitive transformation · refractory tumors · Immune cell infiltration
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026. https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459